Enter your keyword

8053+ OFFICERS SERVING THE NATION UNIVERSAL COACHING CENTRE Let's join hands together in bringing Your Name in Elite officers list. JOIN US 25 YEARS OF EXCELLENCE MEET NEW FRIENDS AND STUDY WITH EXPERTS JOIN US Nothing is better than having friends study together. Each student can learn from others through by teamwork building and playing interesting games. Following instruction of experts, you and friends will gain best scores.

ULP Click here! Click here! Classroom Programme NRA-CET Test Series
Click here ! Org code: XSHWV

post

SHRESTH Initiative Launched to Enhance Drug Quality

Why in the News ?

Union Health Secretary Punya Salila Srivastava launched the State Health Regulatory Excellence Index (SHRESTH) in New Delhi, a CDSCO-led initiative aimed at improving state drug regulatory authorities, ensuring medicine safety, quality, and efficacy through a data-driven benchmarking framework.

Launch and Objectives of SHRESTH Initiative:

  • Launched by: Union Health Secretary Punya Salila Srivastava in New Delhi.
  • Objective: Strengthen drug safety and quality in India by improving the performance of state drug regulatory authorities.
  • Significance: First-of-its-kind national benchmarking system for state regulators.
  • Approach:

    • Transparent and data-driven framework.
    • Recognition of best practices among states and UTs.
    • Focus on continuous improvement in drug manufacturing and distribution oversight.
  • Minister’s Statement:

    • Medicine safety, quality, and efficacy are foundational to public health.
    • Called for Centre–State collaboration to uphold high regulatory standards.

Impact and Future Roadmap:

  • Expected Outcomes:

    • Uniform enforcement of drug quality standards across states.
    • Increased accountability and transparency in regulatory performance.
    • Improved public trust in medicines manufactured and distributed in India.
  • Best Practices Sharing: States with exemplary performance will act as models for others.
  • Technological Integration: Future adoption of digital monitoring tools for real-time compliance checks.
  • Long-Term Vision:

    • Position India as a global leader in safe pharmaceutical production.
    • Ensure zero tolerance towards substandard or counterfeit medicines.

About SHRESTH and CDSCO:

●      SHRESTH: State Health Regulatory Excellence Index.

●      Proposed by: Central Drugs Standard Control Organisation (CDSCO) under the Ministry of Health & Family Welfare.

●      Purpose:

○       Evaluate and rank state drug regulatory systems.

○       Identify gaps and provide support for capacity building.

●      CDSCO’s Role:

○       Acts as the national drug regulatory authority of India.

○       Oversees drug approval, clinical trials, quality control, and licensing.

●      Relevance to Governance:

○       Aligns with National Health Policy goals.

○       Enhances India’s pharmaceutical credibility globally.